Register      Login
Reproduction, Fertility and Development Reproduction, Fertility and Development Society
Vertebrate reproductive science and technology
RESEARCH ARTICLE

10 EFFECT OF ESTRADIOL BENZOATE OR hCG ON DAY 22 AFTER TIMED ARTIFICIAL INSEMINATION ON THE CORPUS LUTEUM SIZE, PROGESTERONE CONCENTRATION, AND PREGNANCY RATE IN RESYNCHRONIZED BEEF HEIFERS

J. B. S. Borges A , H. L. D. Neri A , M. R. Almeida A , E. P. Silva A and A. Bilha A
+ Author Affiliations
- Author Affiliations

Unidade de Reprodução de Bovinos, Faculdade de Veterinária, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Reproduction, Fertility and Development 28(2) 134-135 https://doi.org/10.1071/RDv28n2Ab10
Published: 3 December 2015

Abstract

This study aimed to compare the effects of 2 inducers of new follicular wave [oestradiol benzoate (EB) or hCG] administrated at onset of resynchronization protocols initiated 22 days after the first timed AI (TAI) of beef heifers. We evaluated the effect of treatments on corpus luteum (CL) development, serum progesterone (P4) concentrations, and pregnancy rates. A total of 467 grazing Brangus heifers, with 24- to 26-months, 320 ± 10 kg of body weight, and 3.2 ± 0.5 body condition score, were utilised. The resynchronization protocol began 22 days after the first TAI (Day 22). Heifers were randomly allocated into 1 of 3 groups: EB (n = 199), hCG (n = 101), or control untreated (n = 167). The EB- and hCG-treated heifers received an intravaginal P4 device (Procliclar, 0.75 g of P4; Hertape, Brazil) and an IM treatment with 1 mg of EB (Benzoato HC, Hertape) or 1000 IU of hCG (Vetecor 5000, Hertape), respectively. On Day 30, P4 device was removed, and the pregnancy diagnosis was performed. At this time heifers had the CL area (cm2) determined by ultrasound and seric P4 concentration evaluated by chemiluminescence assay. The assay sensitivity was 0.1 ng mL–1, and the intra- and interassay coefficients of variation were 7.9 and 10.6%, respectively. Nonpregnant heifers after the first TAI (EB = 97, hCG = 36) received intramuscularly 150 μg of sodium cloprostenol (Veteglan Luteolítico, Hertape) and 1 mg of oestradiol cypionate (Cipionato HC, Hertape). The second TAI was performed 48 to 52 h after the P4 device removal. On Day 62, heifers were submitted to a second pregnancy diagnosis. No effect of the body condition score (P = 0.28) was observed on the first and second pregnancy per AI. Pregnancy rates after the first TAI were higher (P = 0.03) on hCG-treated heifers (64.4%) than EB (51.3%) or the control group (58.7%). The EB group determined greater (P = 0.04) pregnancy rate after the second TAI (49.5%) than the hCG group (22.2%). The cumulative pregnancy rates were similar (P = 0.46) between groups [EB (72.4%) and hCG (68.3%)]; however, both were greater (P < 0.05) than the control group (58.6%). Heifers treated with hCG (3.42 ± 0.76) presented greater CL area at Day 30 (P < 0.05) than the EB (2.44 ± 0.57) and control (2.61 ± 0.61) groups. The treatment with hCG 22 days after TAI determined greater (12.43 ± 3.48; P < 0.05) serum P4 concentrations on Day 30 than the EB (6.92 ± 3.04) and control (7.29 ± 2.45) groups. Therefore, the use of hCG at the beginning of resynchronization protocol 22 days after the TAI increased pregnancy rate following the first TAI. However, the use of 1 mg of EB determined greater pregnancy rate after the second TAI, and no detrimental effects on CL development, P4 concentration, and on first TAI pre-established pregnancy.